Another example of using the not obvious drug for cancer treatment can be NPs loaded with orlistat, which is the FDA-approved anti-obesity drug with the ability to block the lipogenic activity of fatty acid synthase (FAS) present in 50% of cancer cells. The gene discussed is FASN; the disease is cancer.